Last updated on June 2016

Investigation of FOL-005 on Clinical Safety and Effect on Hair Growth


Brief description of study

A study to investigate clinical safety and effect on hair growth of FOL-005 in healthy volunteers. The study is divided in two parts, a single ascending dose (SAD) part and a multiple dose (MD) part.

Detailed Study Description

SAD part: A total of 3 weeks dosing, the two lowest concentrations in week 1, dose 3 at week 2 and finally dose 4 at week 3. MD part: In total 12 weeks of dosing where group A will be dosed twice weekly and group B three times weekly Each injection will be administered into one of five of the six randomized areas (10 cm apart, left and right side) from the subject's defined investigational skin areas. One area will be completely untreated.

Clinical Study Identifier: NCT02793557

Contact Investigators or Research Sites near you

Start Over

Ulrike Blume-Peytavi, Professor

Klinik f r Dermatologie, Venerologie und Allergologie, Charit -Universit tsmedizin
Berlin, Germany
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.